Leukocytoclastic vasculitis as a rare adverse effect of ustekinumab in a patient with Crohn’s disease

Authors

  • Hüseyin Aykut Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey
  • Baver Ordu Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey
  • Berkay Dertsiz Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey
  • Gupse Adalı Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey
  • Özben Yalçın Department of Pathology, University of Health Sciences, Prof. Dr. Cemil Taşçıoğlu City Hospital, Istanbul, Türkiye

DOI:

https://doi.org/10.15403/jgld-6036

Keywords:

Crohn's disease, vasculitis, leukocytoclastic, ustekinumab

Downloads

Published

2025-03-28

How to Cite

1.
Aykut H, Ordu B, Dertsiz B, Adalı G, Yalçın Özben. Leukocytoclastic vasculitis as a rare adverse effect of ustekinumab in a patient with Crohn’s disease. JGLD [Internet]. 2025 Mar. 28 [cited 2026 Jul. 22];34(1):137-8. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/6036

Issue

Vol. 34 No. 1: March 2025

Section

Letters